Literature DB >> 15572291

Dietary flavonoids and cancer risk: evidence from human population studies.

Marian L Neuhouser1.   

Abstract

High dietary intake of fruits and vegetables is consistently associated with a reduced risk of common human cancers, including cancers of the lung, breast, prostate, and colon. It is unknown which bioactive compound or compounds in plant foods provide the chemoprotective effects. One class of compounds currently under investigation is flavonoids, a large group of compounds with similar structure, consisting of two phenolic benzene rings linked to a heterocyclic pyran or pyrone. Although there are numerous in vitro and animal model data suggesting that flavonoids influence important cellular and molecular mechanisms related to carcinogenesis, such as cell cycle control and apoptosis, there are limited data from human population studies. This article reviews data from four cohort studies and six case-control studies, which have examined associations of flavonoid intake with cancer risk. There is consistent evidence from these studies that flavonoids, especially quercetin, may reduce the risk of lung cancer. Further research using new dietary databases for food flavonoid content is needed to confirm these findings before specific public health recommendations about flavonoids can be formulated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572291     DOI: 10.1207/s15327914nc5001_1

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  82 in total

Review 1.  Bioavailability challenges associated with development of anti-cancer phenolics.

Authors:  Song Gao; Ming Hu
Journal:  Mini Rev Med Chem       Date:  2010-06       Impact factor: 3.862

2.  Effects of ascorbic acid and β-carotene on HepG2 human hepatocellular carcinoma cell line.

Authors:  Erkan Yurtcu; Ozlem Darcansoy Iseri; Feride I Sahin
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

3.  Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5).

Authors:  Chung-Pu Wu; Anna Maria Calcagno; Stephen B Hladky; Suresh V Ambudkar; Margery A Barrand
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

4.  Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study.

Authors:  Mitali Pandey; Parminder Kaur; Sanjeev Shukla; Ata Abbas; Pingfu Fu; Sanjay Gupta
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

5.  Fruit peel polyphenols demonstrate substantial anti-tumour effects in the model of breast cancer.

Authors:  Peter Kubatka; Andrea Kapinová; Martin Kello; Peter Kruzliak; Karol Kajo; Desanka Výbohová; Silvia Mahmood; Radovan Murin; Tischlerová Viera; Ján Mojžiš; Anthony Zulli; Martin Péč; Marián Adamkov; Monika Kassayová; Bianka Bojková; Nadežda Stollárová; Dušan Dobrota
Journal:  Eur J Nutr       Date:  2015-05-01       Impact factor: 5.614

6.  Molecular structure and anti-proliferative effect of galangin in HCT-116 cells: In vitro study.

Authors:  Ghassan Mohammad Sulaiman
Journal:  Food Sci Biotechnol       Date:  2016-02-29       Impact factor: 2.391

7.  Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor.

Authors:  Darkhan Utepbergenov; Urszula Derewenda; Natalya Olekhnovich; Gabriela Szukalska; Budhaditya Banerjee; Michael K Hilinski; Deborah A Lannigan; P Todd Stukenberg; Zygmunt S Derewenda
Journal:  Biochemistry       Date:  2012-08-06       Impact factor: 3.162

8.  High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults.

Authors:  Raul Zamora-Ros; Montserrat Rabassa; Antonio Cherubini; Mireia Urpí-Sardà; Stefania Bandinelli; Luigi Ferrucci; Cristina Andres-Lacueva
Journal:  J Nutr       Date:  2013-06-26       Impact factor: 4.798

9.  Identification of quercitrin as an inhibitor of the p90 S6 ribosomal kinase (RSK): structure of its complex with the N-terminal domain of RSK2 at 1.8 Å resolution.

Authors:  Urszula Derewenda; Mykhaylo Artamonov; Gabriela Szukalska; Darkhan Utepbergenov; Natalya Olekhnovich; Hardik I Parikh; Glen E Kellogg; Avril V Somlyo; Zygmunt S Derewenda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-01-19

Review 10.  Luteolin, a flavonoid with potential for cancer prevention and therapy.

Authors:  Yong Lin; Ranxin Shi; Xia Wang; Han-Ming Shen
Journal:  Curr Cancer Drug Targets       Date:  2008-11       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.